Active, Not Recruiting
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
NCT05456685
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- University of Arizona Cancer Center /ID# 268906 Tucson, Arizona, United States
- Women'S Cancer Research Network - Cogi /ID# 268912 Fresno, California, United States
- Providence - St. Jude Medical /ID# 268911 Fullerton, California, United States
- Moores Cancer Center /ID# 268888 La Jolla, California, United States